Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens
Visual Performance Differences Between Clareon PanOptix and a Comparable Multifocal Intraocular Lens
Argus Research Center, Inc.
290 participants
May 7, 2025
INTERVENTIONAL
Conditions
Summary
This is a two-part, multi-center, investigator-initiated clinical study comparing visual outcomes and patient satisfaction in subjects receiving bilateral implantation of either the Clareon PanOptix intraocular lens (IOL) or a comparable multifocal IOL. The study includes a retrospective/prospective pilot phase and a prospective, randomized comparison phase.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bilateral implantation of the Clareon PanOptix or PanOptix Toric IOLs.
Bilateral implantation of a comparable multifocal IOL
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07006428